drugset / Trial / NCT00539500
Autologous Stem Cell Rescue With CD133+ Selected Cells in High-Risk Neuroblastoma
NaSingle-groupOpen-labelTreatment
Summary
The goal of this clinical research study is to learn how long it takes for certain types of transplanted stem cells to produce new blood cells. The safety of this treatment will also be studied. Finally, researchers want to learn if collecting the cells with the CliniMACS device can decrease the possibility of tumor cells contaminating (appearing in) the stem cells that are reinfused into participants.
Timeline
- Start
- 2007-10
- Primary completion
- 2012-09-05
- Completion
- 2012-09-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Carboplatin | Small molecule | — | Intravenous |
| Background | Etoposide | Small molecule | 300 mg/m2 | Intravenous |
| Background | Melphalan | Small molecule | 70 mg/m2 | Intravenous |